Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Bioarctic

Biotech & Life Sciences · Stockholm, Sweden · Founded 2003 · IPO 2017 Unicorn

Swedish research-oriented biopharma company

Valuation
$3.22B
Market cap · May/2026
Revenue
$242M
Latest reported FY
EBITDA
$72M
Latest reported FY

Investors

1 investor on Bioarctic's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 1 investor entered at this stage
Uppsala University

Global footprint

Where Bioarctic has talent and traffic

Workforce by country
4 countries with
team presence
🇸🇪 Sweden93.9%
🇫🇮 Finland3.2%
🇩🇰 Denmark1.9%
🇳🇴 Norway1%
4 countries shown
Web traffic by country
10K monthly visits
across markets
🇸🇪 Sweden67%
🇺🇸 United States24%
🇪🇸 Spain14%
🇬🇧 United Kingdom12%
🇮🇳 India12%
Top 5 markets shown

Patent intelligence

$63M patent portfolio · 26 active families

Estimated portfolio value
$63M
2.0% of market cap · 12.3× smaller than top peer BioNTech ($780M)
26 active patent families
Where Bioarctic innovates Molecular biologyAntiendomysial antibodiesBiochemistryAntigen bindingProtease

Where Bioarctic concentrates vs peers

Each axis is a top-10 topic across Bioarctic and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Bioarctic

An AI-synthesized read of the highest-engagement posts about Bioarctic on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Bioarctic on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.